Advertisement

February 22, 2015

SCAI Announces Selections for Emerging Leader Mentorship Program

February 23, 2015—The Society for Cardiovascular Angiography and Interventions (SCAI) announced the selection of 12 early-career interventional cardiologists to participate in the 2015–2017 Emerging Leader Mentorship (ELM) Program. This is a collaborative program developed in 2010 by SCAI with the American College of Cardiology and Cardiovascular Research Foundation. Srihari S. Naidu, MD, and Thomas Tu, MD, serve as the ELM program cochairs.

According to SCAI, 12 promising young physicians will participate in an intense, hands-on, 2-year mentorship program to improve and refine their skills as leaders in medicine, ambassadors for their specialty, and advocates for their patients.

SCAI stated that this year’s emerging leaders were selected from a group of approximately 100 applicants by a steering committee representing all three organizations. They are a diverse group of adult and pediatric interventional cardiologists from both academic and private practices. All were chosen for their leadership potential and motivation to excel both regionally and nationally in the areas of clinical care, scholarship, education, and/or advocacy. 

ELM Fellows meet throughout the program for training sessions designed to help them expand leadership skills, enhance presentation skills, foster relationships, keep up to date on emerging trends, and develop their professional niche. In addition, they are given responsibilities and opportunities to make meaningful contributions to the field of interventional cardiology. Throughout the 2 years, the ELM Fellows will be assisted by mentors who are selected to match their interests, talent, and aspirations. The goal is that the ELM Fellows will make ongoing, perpetual contributions to the field long after the program is completed.

The 2015–2017 ELM class includes:

  • Saif Anwaruddin, MD, Assistant Professor of Medicine, University of Pennsylvania, and Codirector, Transcatheter Valve Program, at the Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania;
  • Ehrin Armstrong, MD, Director, Interventional Cardiology, at Denver VA Medical Center and Eastern Colorado Healthcare System in Denver, Colorado;
  • Adnan Chhatriwalla, MD, Medical Director, Structural Intervention, at Saint Luke’s Cardiovascular Consultants and Saint Luke’s Mid America Heart Institute in Kansas City, Missouri;
  • Payam Dehghani, MD, Director, Adults with Structural Heart Disease Clinic, and Assistant Professor at University of Saskatchewan in Regina, Saskatchewan, Canada;
  • Bryan Goldstein, MD, Assistant Professor, University of Cincinnati College of Medicine, and Attending Physician at Cincinnati Children’s Hospital Medical Center in Cincinnati, Ohio;
  • Dharam Kumbhani, MD, Assistant Professor, University of Texas Southwestern Medical School, and Staff Physician at University Hospital and Parkland Memorial Hospital in Dallas, Texas;
  • Jordan Safirstein, MD, Assistant Director, The Gagnon Cardiovascular Institute, and Clinical Assistant Professor of Medicine at Mount Sinai Medical Center in Morristown, New Jersey;
  • Rahul Sakhuja, MD, Associate Director, Vascular Medicine/Endovascular Intervention Program, and Medical Director, Structural Heart Disease Program, at Wellmont CVA Heart Institute in Kingsport, Tennessee;
  • Arnold Seto, MD, Chief of Cardiology at Long Beach VA Medical Center in Long Beach, California;
  • Binita Shah, MD, Attending Physician at NYU Langone Medical Center, Bellevue Hospital Center, and VA NY Harbor Healthcare System in New York, New York;
  • Rajesh Swaminathan, MD, Director, Interventional Cardiology Research, Assistant Professor of Medicine, Cardiac Catheterization and Endovascular Laboratory, at New York-Presbyterian Hospital-Weill Cornell Medical Center, New York, New York; and
  • Molly Szerlip, MD, Director of Valve Service at The Heart Hospital Baylor Plano, and Program Director, Advanced Structural Interventional Fellow, in Dallas Texas.

 

Advertisement


February 23, 2015

FDA Clears Pie Medical Imaging's CAAS A-Valve System for Measuring Aortic Regurgitation Based on X-Ray Angiography

February 23, 2015

FDA Clears Pie Medical Imaging's CAAS A-Valve System for Measuring Aortic Regurgitation Based on X-Ray Angiography